content top

Ranibizumab vs Bevacizumab vs Combined Therapy PDT-Ranibizumab for the Treatment of Age-related Macular Degeneration: One-year Follow-up

Advantages: To compare the efficiency of three different treatments analyzing the changes in visual acuity (VA), number of used doses and costs. Methods: In a randomized prospective study we created three groups: Group-A, where we administered 0.5 mg (0.05ml) of intravitreal (IV) Ranibizumab, for three consecutive months; Group-B, where we combined the photodynamic therapy together with an IV injection of Ranibizumab; Group-C, where we...

Read More

Choroidal Vasculopathy Polipoydal. PTD guided by ICG. Long-term Period Results

Advantages: To evaluate the long-term outcome of patients suffering from symptomatic polypoidal choroidal vasculopathy (CVP), treated with focal photodynamic therapy (PDT), guided by indocyanine green (ICG). Methods: A prospective study of 11 eyes of 10 patients. Initially treated with focal PDT-VI guided. In 11 eyes the minimum follow up was 12 months, 9 eyes of 24 months, 7 to 36 months, 4 of 48 months and 3 to 60 months. We evaluated...

Read More
content top